Hyperuricemia nephropathy
With the improvement of people's living standards, the extension of life expectancy and the aging of the population, the incidence of hyperuricemia and gout is increasing rapidly. Clinically, hyperuricemia is often accompanied by hyperuricosuria. Both hyperuricemia and hyperuricosuria can cause uric acid (salt) to deposit in kidney tissue and cause renal damage, which is called uric acid nephropathy. Uric acid and urate can cause gout, acute uric acid nephropathy, uric acid kidney stones, chronic gouty nephropathy and asymptomatic hyperuricemia.
-
Site of disease:
kidney -
Infectious :
Not contagious -
Frequent population:
More common in middle-aged and elderly people -
Related symptoms:
Polyuria Proteinuria Nausea Joint swelling and pain Joint pain -
Concurrent disease:
Related Drugs
Probenecid
Indication: It is mainly used in the inter-attack and chronic stages of gout to control hyperuricemia. It is suitable for patients with elevated blood uric acid, good renal function, and low daily uric acid excretion. It is also used to treat hyperuricemia caused by thiazide diuretics or those at risk of gout. It is generally not used as an adjuvant treatment for hyperuricemia caused by cancer treatment. Since this product can inhibit the excretion of penicillin and cephalosporins from the renal tubules and increase their blood drug concentrations, it can be used as an adjuvant treatment for some diseases that require long-term high concentrations of penicillin and cephalosporin blood concentrations, such as subacute infective endocarditis, gonorrhea, etc.
Manufacturer:
Hunan Warrant Chiral Pharmaceutical Co., Ltd.
Related Ingredients
-
Probenecid list
57-66-9